“御敌于国门之外”——病毒入侵抑制剂的研究进展

摘要

25年前,我们在国际上开辟了研发人类免疫缺陷病毒(human immunodeficiency virus,HIV)融合/入侵抑制剂和抗HIV多肽药物的全新领域.近6年来,我们在HIV、中东呼吸综合征冠状病毒(Middle East respiratory syndrome coronavirus,MERS-CoV)、埃博拉病毒(Ebola virus,EBOV)和寨卡病毒(Zika virus,ZIKV)入侵抑制剂的研发工作中取得了一系列重要研究成果.本文概要性地综述了相关高致病性病毒入侵抑制剂的研究进展.%About 25 years ago,we had pioneered the research fields of developing human immunodeficiency virus (HIV) fusion/entry inhibitors and anti-HIV peptide drugs.Over the past six years,we have gained some promising results in research and development of the HIV,Middle East respiratory syndrome coronavirus (MERS-COV),the Ebola virus (EBOV),and the Zika virus (ZIKV) entry inhibitors.This article provides an overview of the research progress of viral entry inhibitors against the related highly pathogenic viruses.